Oracle Health Sciences announced that South Korea’s LSK Global Pharma Services (LSK Global PS) has adopted cloud -based Oracle Health Sciences InForm to improve its clinical development processes.
This apart, LSK Global PS will streamline data capture, and speed up trial timelines with Oracle’s solution.
LSK Global PS offers task flow, product development, regulatory consulting, project development, clinical research, data management, and other CRO services. The company also conducts clinical trials for many local pharmaceutical firms.
“Today, CROs are challenged by increasingly complex global clinical trials, shrinking R&D resources, and smaller budgets — all in a more competitive environment,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences.
The pharmaceutical company plans to utilize Oracle’s technology to gain deeper and faster insight into its clinical data, which will help the company save time and effort.
In turn, the CRO will be able to help sponsors improve the speed, quality, and efficiency of their clinical studies.
Oracle said its Health Sciences InForm offers industry standards, such as CDISC, to increase efficiency and time for trial design and setup and enhance data collection and reporting quality.
Young Jack Lee, chairman and chief executive officer, LSK Global PS said Oracle Health Sciences InForm electronic data capture system is helping it to meet growing global business needs. Moreover, the solution’s data entry displays help to accelerate data collection and improve the end user experience at clinical investigator sites.
In late September, Oracle enhanced its Cloud Platform for Integration with Oracle SOA Cloud Service and Oracle API Manager Cloud Service. The company said the new additions will enable users to quickly integrate on-premises and cloud applications.
Arya MM
